女性盆腔植入物市场
女性盆腔植入物市场：2026年市场规模约为56.2亿美元，2031年市场规模约为61.1亿美元；预测期复合年增长率为6.11%；当前最大市场为北美；增长最快的市场为亚太地区。
市场研究正文
规模、增长、细分、驱动因素与关键问题
当前质量分 100.00，审核状态 accepted。结构化字段已按 RoboInd 内容层级组织。
核心结论
女性盆腔植入物市场：2026年市场规模约为56.2亿美元，2031年市场规模约为61.1亿美元；预测期复合年增长率为6.11%；当前最大市场为北美；增长最快的市场为亚太地区。
市场走势
结构化指标
| 指标 | 年份 | 数值 | 性质 |
|---|---|---|---|
| 复合年增长率 | 2031 | 6.11% | 机构预测 |
| 市场规模 | 2026 | USD 5.62 billion | 机构预测 |
| 市场规模 | 2031 | USD 6.11 billion | 机构预测 |
细分市场份额
市场结构
| 维度 | 细分项 | 年份 | 份额 |
|---|---|---|---|
| end_user | hospitals | 2025 | 57.650% |
| geography | North America | 2025 | 42.430% |
| indication | stress urinary incontinence | 2025 | 72.650% |
| material | polypropylene mesh | 2025 | 51.760% |
| product_type | vaginal mesh implants | 2025 | 45.650% |
关键结论
- end_user 维度中，hospitals 在 2025 年的公开份额为 57.65%。
- geography 维度中，North America 在 2025 年的公开份额为 42.43%。
- indication 维度中，stress urinary incontinence 在 2025 年的公开份额为 72.65%。
- material 维度中，polypropylene mesh 在 2025 年的公开份额为 51.76%。
- product_type 维度中，vaginal mesh implants 在 2025 年的公开份额为 45.65%。
主要参与者
- Boston Scientific Corporation
- Caldera Medical
- Promedon Group
- Johnson & Johnson Services, Inc.
- Becton, Dickinson and Company
增长驱动因素
| 因素 | 影响 CAGR | 地区相关性 | 影响周期 |
|---|---|---|---|
| Rising Prevalence of Pelvic Organ Prolapse and Stress Urinary Incontinence | +1.900% | Global, strongest in South Asia, Andean Latin America, and Sub-Saharan Africa | Long term (≥ 4 years) |
| Increasing Adoption of Minimally Invasive Outpatient Procedures | +1.300% | North America and Europe, with spillover to core Asia-Pacific markets | Medium term (2-4 years) |
| Aging and Post-Menopausal Female Population | +1.100% | Global, strongest in Japan, Germany, Italy, and the United States | Long term (≥ 4 years) |
| Lightweight and Adjustable Implant Innovation | +0.800% | North America, the European Union, and Japan | Medium term (2-4 years) |
| Expanding Urogynecology Access and Reimbursement | +0.700% | North America and the European Union, with spillover to the GCC | Short term (≤ 2 years) |
| Postoperative Digital Monitoring and Personalized Patient Selection | +0.400% | North America and Western Europe | Medium term (2-4 years) |
市场制约因素
| 因素 | 影响 CAGR | 地区相关性 | 影响周期 |
|---|---|---|---|
| Mesh-Related Complications and Revision Risk | -1.100% | Global, strongest in North America and the European Union | Long term (≥ 4 years) |
| Regulatory Restrictions on Transvaginal POP Mesh | -0.900% | United States, United Kingdom, Canada, Australia, and selected European Union markets | Long term (≥ 4 years) |
| High Procedure Cost and Uneven Reimbursement | -0.600% | Asia-Pacific excluding Japan, the Middle East and Africa, and South America | Medium term (2-4 years) |
| Limited Specialist Training and Delayed Diagnosis | -0.400% | Global, strongest in South Asia, the Middle East and Africa, and Latin America | Long term (≥ 4 years) |
报告关注的关键问题
What is the projected value of female pelvic implants by 2031?
The female pelvic implants market is forecast to reach USD 7.57 billion by 2031, growing at a 6.11% CAGR from 2026.
Which product category is growing fastest?
Vaginal sling implants are projected to grow at an 8.54% CAGR through 2031.
Why are ambulatory surgical centers important?
They are forecast to grow at a 9.76% CAGR and benefit from outpatient reimbursement expansion.
Which indication has the greatest demand?
Stress urinary incontinence represented 72.65% of value in 2025 and is forecast to grow at an 8.45% CAGR.
What is the principal U.S. restriction on pelvic mesh?
The FDA prohibits surgical mesh for transvaginal pelvic organ prolapse repair, while full-length mid-urethral slings remain distinct.
Which region is growing fastest?
Asia-Pacific is forecast to expand at a 7.43% CAGR through 2031.
市场概览
- 增长最快市场：亚太地区
- 最大市场：北美
- 市场集中度：中等
查看来源：Mordor Intelligence